The Effects of the Tyrosine Kinase Inhibitor AG1478 in a Repeated Allergen Challenge Model of Asthma

被引：0
|
作者：
Siddiqui, S. [1 ]
Jo, T. [1 ]
Tsuchiya, K. [1 ]
Martin, J. G. [1 ]
机构：
[1] McGill Univ, Meakins Christie Labs, Montreal, PQ, Canada
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2009年 / 179卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A5057
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The AG1478 tyrosine kinase inhibitor is an effective suppressor of leiomyoma cell growth
    Shushan, A
    Rojansky, N
    Laufer, N
    Klein, BY
    Shlomai, Z
    Levitzki, R
    Hartzstark, Z
    Ben-Bassat, H
    HUMAN REPRODUCTION, 2004, 19 (09) : 1957 - 1967
  • [2] Effect of Tyrosine Kinase Inhibitor AG1478 on Internalized EGF Receptor in A431 Cells
    Kondratov, K.
    Kornilova, E.
    MOLECULAR BIOLOGY OF THE CELL, 2006, 17
  • [3] Inhibiting the function of ABCB1 and ABCG2 by the EGFR tyrosine kinase inhibitor AG1478
    Shi, Zhi
    Tiwari, Amit K.
    Shukla, Suneet
    Robey, Robert W.
    Kim, In-Wha
    Parmar, Smitaben
    Bates, Susan E.
    Si, Qiu-Sheng
    Goldblatt, Curtis S.
    Abraham, Ioana
    Fu, Li-Wu
    Ambudkar, Suresh V.
    Chen, Zhe-Sheng
    BIOCHEMICAL PHARMACOLOGY, 2009, 77 (05) : 781 - 793
  • [4] Micro-solvation of tyrosine-kinase inhibitor AG1478 explored with fluorescence spectroscopy and computational chemistry
    Khattab, Muhammad
    Wang, Feng
    Clayton, Andrew H. A.
    RSC ADVANCES, 2017, 7 (50) : 31725 - 31735
  • [5] Photodynamic targeting of EGFR does not predict the treatment outcome in combination with the EGFR tyrosine kinase inhibitor Tyrphostin AG1478
    Weyergang, Anette
    Kaalhus, Olav
    Berg, Kristian
    PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES, 2008, 7 (09) : 1032 - 1040
  • [6] Photodynamic targeting of EGFR does not predict the treatment outcome in combination with the EGFR tyrosine kinase inhibitor Tyrphostin AG1478
    Anette Weyergang
    Olav Kaalhus
    Kristian Berg
    Photochemical & Photobiological Sciences, 2008, 7 : 1032 - 1040
  • [7] EGFR tyrosine kinase inhibitor AG1478 inhibits cell proliferation and arrests cell cycle in nasopharyngeal carcinoma cells
    Zhu, XF
    Liu, ZC
    Xie, BF
    Li, ZM
    Feng, GK
    Yang, DJ
    Zeng, YX
    CANCER LETTERS, 2001, 169 (01) : 27 - 32
  • [8] The epidermal growth factor tyrosine kinase inhibitor AG1478 and erlotinib reverse ABCG2-mediated drug resistance
    Shi, Zhi
    Parmar, Smitaben
    Peng, Xing-Xiang
    Shen, Tong
    Robey, Robert W.
    Bates, Susan E.
    Fu, Li-Wu
    Shao, Yining
    Chen, Yang-Min
    Zang, Feiyang
    Chen, Zhe-Sheng
    ONCOLOGY REPORTS, 2009, 21 (02) : 483 - 489
  • [9] Combination of the EGFR Tyrosine Kinase Inhibitor AG1478 and 5-FU: No Synergistic Effect on EGFR Phosphorylation, Cell Proliferation and Apoptosis Induction
    Yagublu, Vugar
    Ahmadova, Zhala
    Hajiyeva, Yegana
    Hafner, Mathias
    Keesei, Michael
    ANTICANCER RESEARCH, 2013, 33 (09) : 3753 - 3758
  • [10] Human glioblastoma xenografts overexpressing a tumor-specific mutant epidermal growth factor receptor sensitized to cisplatin by the AG1478 tyrosine kinase inhibitor
    Nagane, M
    Narita, Y
    Mishima, K
    Levitzki, A
    Burgess, AW
    Cavenee, WK
    Huang, HJS
    JOURNAL OF NEUROSURGERY, 2001, 95 (03) : 472 - 479
12345